Premier Inc (PINC) Q4 2025 Earnings Call Highlights: Exceeding Expectations and Strategic ...
Total Full Year Revenue: $986 million, $11 million above the midpoint of the guidance range.
Adjusted EPS: $1.54, $0.11 above the high end of the guidance range.
Fourth Quarter Net Revenue: $258 million, increased 1% sequentially.
GAAP Net Income and EPS: $18 million or $0.22 per share.
Adjusted EBITDA: $71 million, with a margin of 27.6%.
Adjusted EPS for Q4: $0.46.
Free Cash Flow: $181 million, with a conversion rate of 69%.
Cash and Cash Equivalents: $84 million as of June 30.
Outstanding Balance on Credit Facility: $280 million.
Fiscal Year 2026 Guidance - Total Net Revenue: $940 million to $1 billion.
Fiscal Year 2026 Guidance - Adjusted EBITDA: $230 million to $245 million.
Fiscal Year 2026 Guidance - Adjusted EPS: $1.33 to $1.43.
Q1 Guidance - Total Net Revenue: $230 million to $245 million.
Q1 Guidance - Adjusted EBITDA: $45 million to $50 million.
Q1 Guidance - Adjusted EPS: $0.27 to $0.32.
Warning! GuruFocus has detected 11 Warning Signs with PINC.
Release Date: August 19, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
Premier Inc (NASDAQ:PINC) exceeded expectations in revenue and profitability, driven by strong performance in the Supply Chain Services segment.
The company completed a $200 million accelerated share repurchase program, returning significant capital to stockholders.
Premier Inc (NASDAQ:PINC) signed four large advisory deals and has a robust pipeline heading into fiscal 2026, indicating strong demand for its services.
The acquisition of IllumiCare enhances Premier Inc (NASDAQ:PINC)'s ability to deliver real-time insights at the point of care, leveraging AI capabilities.
The company's pharmacy and food portfolio continues to grow, attracting new members and serving as key differentiators within its GPO business.
Negative Points
Premier Inc (NASDAQ:PINC) faces significant headwinds such as reimbursement cuts, which are forcing health systems to rethink their cost structures.
The Performance Services segment showed lower enterprise license revenue due to tough comparisons with the prior year.
The company is still working to rebuild its sales funnel in the advisory business, despite recent large contract wins.
Free cash flow decreased year-over-year due to higher performance-related compensation payments and timing of payments to Omnia.
Premier Inc (NASDAQ:PINC) anticipates lower revenue and profitability in the first half of fiscal year 2026 due to the ramp-up of headcount to support advisory business success.
Q & A Highlights
Q: Can you discuss any changes in customer buying behavior in the Supply Chain Services segment, particularly in relation to potential tariffs? A: Michael Alkire, President and CEO, stated that there was no significant pull forward of buying behavior due to tariffs. Any increases observed were primarily due to regional issues rather than tariff-related concerns.
Q: What is driving the momentum in the advisory business, and how much of it is market-driven versus execution on your end? A: Michael Alkire highlighted that the momentum is driven by market needs due to financial pressures on health systems and the strong execution by the team led by Dave Zito, President of Performance Services. The advisory business has signed four large deals recently, indicating strong market demand and execution.
Q: Can you provide more details on the progress of the GPO contract renewals and the expected fee share stabilization? A: Glenn Coleman, Chief Financial and Administrative Officer, explained that the fee share is expected to increase to the mid-60% range in fiscal year 2026, with stabilization in the high 60s once all renewals are addressed. The process is nearing completion, with less than 20% of contracts remaining to be renewed.
Q: Could you provide insights into the financial impact and strategic importance of the IllumiCare acquisition? A: Michael Alkire emphasized that IllumiCare addresses critical member pain points, offering significant savings per patient discharge and enhancing clinical decision support capabilities. Glenn Coleman added that IllumiCare is expected to contribute $8 million to $10 million in revenue for fiscal year 2026 and is breakeven on the bottom line.
Q: What are the expectations for revenue and EBITDA growth in fiscal year 2027, and what factors will drive this growth? A: Glenn Coleman stated that growth in fiscal year 2027 will be driven by increased software business renewals, continued advisory business momentum, and synergies from the IllumiCare acquisition. Additionally, lower fee share headwinds and growth in Supply Chain Services are expected to contribute to the rebound.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
21 minutes ago
- Yahoo
On Holding AG (ONON): I'm Double Minded About The Stock, Says Jim Cramer
We recently published . On Holding AG (NYSE:ONON) is one of the stocks Jim Cramer recently discussed. On Holding AG (NYSE:ONON) is an athletic apparel retailer whose stock has lost 18% year-to-date on the back of investor concerns about the broader retail industry. The shares dipped by 8% last week after Tapestry warned that it expected tariffs to hit its profits. Cramer discussed the movement in On Holding AG (NYSE:ONON)'s shares and warned that he might have been too bullish about the firm previously. Here is what he said: 'A lot of the apparel stocks are down off of Tapestry. I've got to tell you, I mean Ralph Lauren is too. But the one that I've been watching is On Holding. I thought On Holding had a good quarter. I've been either disabused of that notion or perhaps I've been too bullish about these guys. If ONON is not doing as well, then you have to start thinking about Nike again. ' Mbuso Sydwell Nkosi/ Here are his previous comments about On Holding AG (NYSE:ONON): 'One of my favorite companies is On Holding. Now it has been stuck in a holding pattern. They reported very good numbers today, the stock was initially up seven, now it's down. There's a substantial short position, the shorts have been winning in this battle. I think Roger Federer in the end wins. But it is a very contested group.' While we acknowledge the potential of ONON as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
21 minutes ago
- Yahoo
Tech Stocks Are Under Pressure. Why Some Wall Street Analysts Say That May Not Last
Tech stocks are having a rough day, extending their recent slump amid a sector rotation away from big tech leaders. The Nasdaq lost close to 1% in recent trading, and the S&P 500 slid 0.4% as tech sector losses weighed on the indexes. The Dow Jones Industrial Average was little changed as retail and consumer defensive names gained, while Amazon (AMZN), Apple (AAPL), and Nvidia (NVDA) ranked among its weakest performers as all of the "Magnificent Seven" stocks declined. Caution ahead of a speech from Federal Reserve Chair Jerome Powell on Friday, uncertainty about policy changes from the Trump administration, and worries about returns from AI spending have all added to pressures on the sector. However, some Wall Street analysts said they don't expect that to last long. "While some near-term tech volatility is not surprising given the run-up in valuations, we advise investors against becoming overly defensive," UBS said Wednesday. "While we think some caution may be warranted in the more cyclical parts of tech, we remain confident in the broader AI sector's long-term growth and resilience. We recommend investors seek balanced exposure across the AI value chain (infrastructure, semis, and applications), with a preference for laggards offering a more attractive risk-reward balance," UBS said. "We view tech sell-offs like yesterday as opportunities," bullish analysts at Wedbush told clients in a note Wednesday, suggesting the slump could be short-lived, and pointed to earnings from AI chipmaker Nvidia next week as a potential positive catalyst. "When Nvidia reports earnings next week on August 27th the tech world and Wall Street will be listening closely," they said, adding that they believe the "tech bull cycle will be well intact at least for another 2-3 years given the trillions being spent on AI." Read the original article on Investopedia Sign in to access your portfolio
Yahoo
21 minutes ago
- Yahoo
Jim Cramer Says Reports Of Apple Inc. (AAPL)'s 'Death' Are Overblown
We recently published . Apple Inc. (NASDAQ:AAPL) is one of the stocks Jim Cramer recently discussed. Giuseppe Costantino/ Apple Inc. (NASDAQ:AAPL)'s shares have reversed tack recently as the firm appears to have smoothed over its friction with the Trump administration. The firm announced a $100 billion additional investment in the US earlier this month, and the shares have gained 13.8% since then. Cramer discussed Apple Inc. (NASDAQ:AAPL)'s shares adding 30 dollars to their value in ten days: 'Well we've got a lot of exciting things that people are talking about. About the release perhaps of new AI powered products. Uh, smart home push, including robots. Life like version of Siri, well that would certainly be helpful. Smart speaker with display and home security camera. I don't know, home security is something that people want but the main thing here is that if we get robots and they're not from Musk, they're from Apple, I think we'd be very interested in that. While we acknowledge the potential of AAPL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
